Methylphenidate-Induced Neuroleptic Malignant Syndrome: A Case Report

View This PDF

NB: This article is only available as a PDF.

Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.

Sir: Methylphenidate is a piperidine derivative, structurally related to amphetamines. It reaches peak blood concentration in 2 hours and has a short half-life of 1 to 2 hours. Its onset of action occurs shortly after dosing, and it can cause increased wakefulness, energy, alertness, and physical and mental performance. Its side effects include anorexia, weight loss, slow growth, insomnia, dysphoria, tics, and psychosis.​

Prim Care Companion J Clin Psychiatry 2006;8(1):47-47 [letter]

https://doi.org/10.4088/PCC.v08n0109a